Home - Medical Policies - Florida
Policies & Guidelines
- Advanced Imaging
- Behavioral Health
- Chronic Condition Management
- Genetic Testing
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pre-Service Review (Precertification/Predetermination)
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Provider-Administered Oncology Drug Policies
Expand the Policies & Guidelines menu on the left to select current, draft or previous Provider-Administered Oncology Drug Policies.
Precertification is required through AIM as part of the Oncology Select program. Providers request authorization through the AIM ProviderPortal accessed through their Plan's website.
Node: bclrgrpappp1001.corp.bcbsal.org:8080